Teva Pays California $69M To Settle Probe That It Paid To Delay Generic Competitors
SAN FRANCISCO — The California Attorney General’s Office on July 29 announced that drug maker Teva Pharmaceutical Industries Ltd. will pay $69 million to settle allegations that it entered into pay-to-delay...To view the full article, register now.
Already a subscriber? Click here to view full article